藏红花酸酯市场规模和占有率分析：依应用（功能性食品和饮料、药品）-全球收入估算和需求预测（截至 2030 年）

全球藏花酸酯市场规模预计将从2023年的411,300美元成长到2030年的634,300美元，预测期内复合年增长率为6.5%。

这是由于人们对以植物为基础的天然成分作为功能性食品和营养补充剂中合成成分的替代品越来越感兴趣。不断增长的健康和保健趋势、消费者意识的提高、监管环境以及这些化学物质在营养和医学中的使用也正在推动行业扩张。继续研究探索藏花酸酯的健康益处和可行应用也进一步推动产业成长。

人口成长和增加粮食产量的需求也推动了该产业的成长。在高度都市化的国家，耕地有限，因此提高现有农业用地的生产力至关重要。透过减少养分外流，藏花酸酯使植物更容易获得养分，促进植物发育并提高作物产量。

市场洞察：

2023 年，欧洲的产业占有率最大，达到 45%。该地区的优势在于自古以来就接受藏红花。藏红花是藏红花酯的原料，该地区各地长期以来都有种植，主要集中在义大利、希腊和西班牙。

预计亚太地区未来几年将以 10% 的最快复合年增长率成长。这是由于该地区对功能性食品和饮料的需求不断增长，以及人们越来越关注与抗氧化剂相关的医疗益处。此外，亚太国家的消费者越来越注重健康，因此不仅对天然成分而且对功能性食品成分的需求也很高。

本报告调查了全球藏红花酸酯市场，并提供了市场定义和概述、市场影响因素分析、市场规模趋势和预测、各个细分市场/地区/主要国家的详细分析、竞争环境和主要公司概况的集合等。

目录

第1章 调查范围

第2章 研究方法

第3章 执行摘要

第4章 市场指标

第5章 产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/问题
  • 促进因素和抑制因素影响分析
• COVID-19 的影响
• 波特五力分析

第6章 世界市场

• 概述
• 市场收入趋势/预测：依应用分类
• 市场收入趋势与预测：依地区

第7章 北美市场

第8章 欧洲市场

第9章 亚太市场

第10章 拉丁美洲市场

第11章 中东/非洲市场

第12章 美国市场

第13章 加拿大市场

第14章 德国市场

第15章 法国市场

第16章 英国市场

第17章 义大利市场

第18章 西班牙市场

第19章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章 南非市场

第28章 阿联酋市场

第29章 竞争格局

• 主要企业及产品一览表
• 各大公司的竞争对标
• 主要公司的产品基准
• 近期策略发展

第30章 公司简介

• Chengdu Biopurify Phytochemicals Ltd.
• Chengdu Gelipu Biotechnology Co. Ltd.
• Tokyo Chemical Industry Co. Ltd
• Amadis Chemical Company Limited
• Hunan Jiahang Pharmaceutical Technology Co. Ltd.
• Cayman Chemical
• Biosynth
• Plamed Green Science Group
• Shaanxi UndersunBiomedtech Co. Ltd.
• Chongqing Kang Biotechnology Co. Ltd.
• Hainan Super Biotech Co. Ltd.
• Xi'an Sgonek Biological Technology Co. Ltd.
• Kingherbs Limited
• Xi'an Lyphar Biotech Co. Ltd.

第31章 附录

Key Highlights

The crocetin esters market was valued at USD 411.3 thousand in 2023, and it will increase to USD 634.3 thousand, advancing at a 6.5% compound annual growth rate, by 2030.

This is because of the increasing interest in plant-based and natural items as a replacement for synthetic ingredients in functional foods and dietary supplements.

The rising trends of health & wellness, growing consumer consciousness, the regulatory situation, and the usage of these chemicals in nutrition and medicine are also helping the industry expand.

The continuing studies to explore the health benefits and viable applications of crocetin esters are further assisting the growth of the industry.

These mixtures are being examined for their possible role in decreasing oxidative stress, supporting cognitive well-being, and controlling CVDs.

The rising populace and the requirement to enhance food production are also aiding the growth of this industry.

With limited arable land in well-urbanized nations, it has become vital to enhance the productivity of the present farmlands.

Crocetin esters assist in optimizing the accessibility of nutrients for plants by reducing their draining, thus enhancing plant development, which can result in greater crop yields.

Market Insights

Europe accounted for the largest share of the industry in 2023, with a 45% share.

The dominance of this region in the enduring understanding of saffron as well as its acceptance.

Saffron, from which crocetin esters are produced, has been farmed in various areas of this region for quite a long time, notably in Italy, Greece, and Spain.

APAC will advance at the fastest compound annual growth rate, of 10%, in the years to come.

This will be because of the region's rising need for functional foods & beverages and the growing concentration of the medical benefits linked to antioxidants.

Natural as well as functional food ingredients are in high demand because customers in APAC nations become more conscious of their well-being.

The functional food and beverage category accounted for the largest share of the industry in 2023, with a 60% share.

Crocetin esters are progressively being employed in confectionery, dairy, beverages, and convenience foods, because of their important part in protecting these products' stability.

They, similarly, assist in increasing the taste, aroma, and assortment of food & beverages.

Functional foods fulfill people's everyday nutrition requirements, as a result, customers are increasingly searching for them for their overall wellbeing.

Pharmaceuticals will advance at a rapid compound annual growth rate, of 8%, in the years to come.

Due to the robust anti-inflammatory, neuroprotective, and antioxidant features of crocetin esters, pharmaceutical firms have been progressively using them as APIs or various other ingredients in the formulations of drugs.

A growing count of clinical trials and studies are being performed on these bioactive substances to explore their possible therapeutic applications for cardiovascular illnesses, neurological disorders, and tumors.

In the crocetin esters industry, competition circles around the introduction of saffron-derived extracts and research on applications of these mixtures in cosmetics, functional foods, and pharmaceuticals.

The competition in this industry is rather tough, with the existence of several globally operating and localized participants.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by application
  • 1.4.2. Market size breakdown, by region
  • 1.4.3. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Application (2017-2030)
• 6.3. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Application (2017-2030)
• 7.3. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Application (2017-2030)
• 8.3. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Application (2017-2030)
• 9.3. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Application (2017-2030)
• 10.3. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Application (2017-2030)
• 11.3. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Application (2017-2030)
• 12.3. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Application (2017-2030)
• 13.3. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Application (2017-2030)
• 14.3. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Application (2017-2030)
• 15.3. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Chengdu Biopurify Phytochemicals Ltd.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Chengdu Gelipu Biotechnology Co. Ltd.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Tokyo Chemical Industry Co. Ltd
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Amadis Chemical Company Limited
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Hunan Jiahang Pharmaceutical Technology Co. Ltd.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Cayman Chemical
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Biosynth
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Plamed Green Science Group
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Shaanxi UndersunBiomedtech Co. Ltd.
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Chongqing Kang Biotechnology Co. Ltd.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. Hainan Super Biotech Co. Ltd.
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary
• 30.12. Xi'an Sgonek Biological Technology Co. Ltd.
  • 30.12.1. Business overview
  • 30.12.2. Product and service offerings
  • 30.12.3. Key financial summary
• 30.13. Kingherbs Limited
  • 30.13.1. Business overview
  • 30.13.2. Product and service offerings
  • 30.13.3. Key financial summary
• 30.14. Xi'an Lyphar Biotech Co. Ltd.
  • 30.14.1. Business overview
  • 30.14.2. Product and service offerings
  • 30.14.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports